How important is Pfizer’s new COVID-19 antiviral likely to be? The US pharmaceutical company has said clinical trial results of its new COVID-19 pill are ‘game-changing’. Experts give newsGP their take on its likely impact.
Under-12s will not be vaccinated against COVID-19 until 2022 The TGA is waiting for more data before it decides whether to approve the Pfizer vaccine for children aged 5–11.
‘A complex decision’: COVID-19 vaccination and younger children The rollout of Pfizer for children aged 5–11 has been given the green light in the US. What is that likely to mean for vaccinators in Australia?
GPs to receive access to Moderna, DoH confirms The RACGP has welcomed the news, which will add another string to GPs’ bow in their efforts to vaccinate Australians against COVID.
Sixty new cases of myocarditis in TGA’s latest safety report The rare side effect has been more common in adolescent boys after receiving the second dose of mRNA vaccine.
‘We need more support’: No extra funding for booster program A COVID-19 vaccine booster program has now been officially signed off, but GPs will miss out on additional remuneration for administering a third dose.
GPs to take central role in vaccine booster rollout What will the new COVID-19 vaccine booster program mean for general practices around the country?
Results from first ‘gold standard’ COVID booster vaccine trial With an announcement pending on Pfizer vaccine boosters in Australia, a new trial suggests they increase vaccine efficacy to 95.6%.
New insight into vaccines’ protection against Delta deaths AstraZeneca and Pfizer offer at least 90% protection from death caused by the Delta variant of the SARS-CoV-2 virus, new international analysis suggests.
How to access Medicare support for third COVID vaccine doses GPs can conduct suitability assessments and administer third doses with the same item numbers used for second doses.